- Home
- NEO vs CCS Comparison
NEO vs CCS Comparison
Compare NEO & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- CCS
- Stock Information
- Founded
- NEO 2001
- CCS 2000
- Country
- NEO United States
- CCS United States
- Employees
- NEO N/A
- CCS N/A
- Industry
- NEO Precision Instruments
- CCS Homebuilding
- Sector
- NEO Health Care
- CCS Consumer Discretionary
- Exchange
- NEO Nasdaq
- CCS Nasdaq
- Market Cap
- NEO 2.3B
- CCS 2.7B
- IPO Year
- NEO 1999
- CCS 2014
- Fundamental
- Price
- NEO $14.18
- CCS $75.85
- Analyst Decision
- NEO Strong Buy
- CCS Buy
- Analyst Count
- NEO 10
- CCS 4
- Target Price
- NEO $20.56
- CCS $104.00
- AVG Volume (30 Days)
- NEO 1.2M
- CCS 418.5K
- Earning Date
- NEO 02-18-2025
- CCS 01-29-2025
- Dividend Yield
- NEO N/A
- CCS 1.37%
- EPS Growth
- NEO N/A
- CCS 30.75
- EPS
- NEO N/A
- CCS 10.03
- Revenue
- NEO $644,118,000.00
- CCS $4,330,440,000.00
- Revenue This Year
- NEO $12.98
- CCS $19.66
- Revenue Next Year
- NEO $9.94
- CCS $14.46
- P/E Ratio
- NEO N/A
- CCS $7.56
- Revenue Growth
- NEO 12.06
- CCS 18.13
- 52 Week Low
- NEO $12.13
- CCS $68.49
- 52 Week High
- NEO $19.11
- CCS $108.42
- Technical
- Relative Strength Index (RSI)
- NEO 40.28
- CCS 47.49
- Support Level
- NEO $13.93
- CCS $68.49
- Resistance Level
- NEO $16.18
- CCS $79.07
- Average True Range (ATR)
- NEO 1.13
- CCS 2.17
- MACD
- NEO -0.33
- CCS 1.06
- Stochastic Oscillator
- NEO 29.37
- CCS 69.58
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
About CCS Century Communities Inc.
Century Communities Inc is a construction company that focuses on the residential market. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its own sales representatives and independent real estate brokers. It also advertises directly to potential homebuyers through the Internet, newspapers, and trade publications. The company generates the majority revenue from the Mountain segment.